Abstract
Testing is central, early detection of the virus minimizes its further spread and allows rapid treatment of the sick - said the head of the South Korean Ministry of Foreign Affairs Kang Gyung Hua. He believes effective management and tests are key to our very low mortality rate. South Korea's health and public administration system was able to quickly protect the population from COVID-19 without the imposition of emergency measures. The adviser to the Swedish government and the Secretary-General of the World Health Organization, Yuhan Gizeke, told the RBC in an interview on May 5, 2020 that the authorities of the country relied on two measures in the fight against coronavirus whose benefit has scientific justification. First, we need to wash our hands, which we've known for 150 years. Second, social distance should be respected, that is, not to get too close to other people. Until May 5, 2020, Sweden recorded only 23216 cases of coronavirus infection. Developed countries have begun to develop a vaccine to combat COVID-19. Any vaccine contains a specific antigen - a protein that provokes antibody production - immune response. In the body antigen is met with specially adapted cells - macrophages. They get acquainted with the antigen and read information from it, - explains Alimbarov. - The obtained information they transmit to T lymphocytes, which in turn begin to change, and among them appear cells that will also participate in the immune process. T cells transmit information to B lymphocytes, which are converted into plasma cells capable of producing antibodies. Part of B lymphocytes is converted into memory cells. They store information about the antigen and, upon repeated encounter with a similar antigen, trigger an immune response (antibody formation) in a shorter time frame. The vaccine can be live (weakened virus), inactivated (dead virus) or vector - that's what the coronavirus vaccine will be. It contains a human-harmless adenovirus whose DNA contains the coronavirus gene. The adenovirus is then used as a delivery container.
Highlights
An outbreak of COVID-19 disease caused by SARS-CoV2 virus occurred in Wuhan, China, in late December 2019
20 Evgeniy Bryndin and Irina Bryndina: Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction vision, willingness and managerial will to protect the population from COVID-19
Scientists have found that only 30 percent of patients who have suffered from COVID-19 have blood serum suitable for the treatment of seriously ill patients
Summary
An outbreak of COVID-19 disease caused by SARS-CoV2 virus occurred in Wuhan, China, in late December 2019. At the beginning of the spread of the infection, South Korea became one of the major hotbeds of the disease outside China. South Korea has proved by its example that the virus can be contained without stopping the economy. To relieve the increased burden on hospitals, 633 centres have been set up in the country, designed for coronavirus testing only, including 50 stations in parking lots in which people can pass the test without leaving their cars. There they fill out the questionnaire, they measure the temperature and take a smear from the throat.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Management Science and Engineering
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
